Ribomic Inc.

2026/10/09 19:27 Updated
Market Cap: $25.4M (¥4.0B)
Stock Price: $0.45 (¥71)
Exchange Rate: 1 USD = ¥158.23

Notice of First Case Registration in Domestic Phase III Clinical Trial of Treatment for Achondroplasia (umedaptanib pegol)

Importance:
Page Updated: September 21, 2026
IR Disclosure Date: July 2, 2026
Other

Ribomic Inc.

Company overview · Stock price · Financial data · All IR

View company page →